StockData
TransMedics Group, Inc. logo

TransMedics Group, Inc. (TMDX) stock

TMDXNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 14/3030% below fair value
$93.91+1.70 (+1.84%)

Close on Nov 17, 2026Market cap $3.26BP/E 24.4Yield 0.00%

TransMedics r&d expenses

Research and development expenses are spending on new products and technology.

TransMedics's R&D Expenses for the twelve months ending Jun 30, 2026 was $92.47M, up 44.9% year over year. For fiscal 2025 it was $69.06M, up 23.4% from the year before. The highest annual figure on record is $69.06M in fiscal 2025.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$69.06M+23.4%
FY2024Dec 31, 2024$55.97M+55.2%
FY2023Dec 31, 2023$36.06M+34.5%
FY2022Dec 31, 2022$26.81M+20.2%
FY2021Dec 31, 2021$22.30M+18.4%
FY2020Dec 31, 2020$18.83M-5.2%
FY2019Dec 28, 2019$19.87M+45.5%
FY2018Dec 29, 2018$13.66M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$31.63M+98.5%
Q1 FY2026Mar 31, 2026$24.88M+45.0%
Q4 FY2025Dec 31, 2025$20.70M+25.7%
Q3 FY2025Sep 30, 2025$15.26M+7.0%
Q2 FY2025Jun 30, 2025$15.93M+15.0%
Q1 FY2025Mar 31, 2025$17.16M+50.8%
Q4 FY2024Dec 31, 2024$16.46M+53.0%
Q3 FY2024Sep 30, 2024$14.27M+28.2%
Q2 FY2024Jun 30, 2024$13.86M+67.1%
Q1 FY2024Mar 31, 2024$11.38M+93.8%
Q4 FY2023Dec 31, 2023$10.76M+87.0%
Q3 FY2023Sep 30, 2023$11.13M+63.5%
Q2 FY2023Jun 30, 2023$8.29M+23.5%
Q1 FY2023Mar 31, 2023$5.87M-22.1%
Q4 FY2022Dec 31, 2022$5.76M-8.8%
Q3 FY2022Sep 30, 2022$6.81M+31.9%
Q2 FY2022Jun 30, 2022$6.71M+6.7%
Q1 FY2022Mar 31, 2022$7.53M+66.2%
Q4 FY2021Dec 31, 2021$6.31M+38.8%
Q3 FY2021Sep 30, 2021$5.16M+24.3%
Q2 FY2021Jun 30, 2021$6.30M+61.3%
Q1 FY2021Mar 31, 2021$4.53M-27.2%
Q4 FY2020Dec 31, 2020$4.55M-27.4%
Q3 FY2020Sep 30, 2020$4.16M-15.9%
Q2 FY2020Jun 30, 2020$3.90M-18.5%
Q1 FY2020Mar 31, 2020$6.23M+60.4%
Q4 FY2019Dec 28, 2019$6.26M+79.6%
Q3 FY2019Sep 28, 2019$4.94M+50.9%
Q2 FY2019Jun 29, 2019$4.79M+39.4%
Q1 FY2019Mar 30, 2019$3.88M+12.0%
Q4 FY2018Dec 29, 2018$3.49M–
Q3 FY2018Sep 29, 2018$3.27M–
Q2 FY2018Jun 30, 2018$3.43M–
Q1 FY2018Mar 31, 2018$3.47M–

More TransMedics figures

See a number that looks wrong?